Preclinical Safety Assessment Vaccines
Preclinical Safety Assessment of Vaccines: Regulatory Expectations, Key Studies and Adgyl Lifesciences’ Expertise in Vaccine Development Introduction Vaccines remain one of the most effective public health interventions, preventing an estimated 3.5 to 5 million deaths annually worldwide. Reflecting their growing importance, approximately 7.2 billion vaccine doses were supplied globally in 2024. As vaccine technologies continue […]